the latest biomarker data that will help identify patients who will benefit from Bexmarilimab treatment. This will potentially increase the likelihood of a positive future pivotal trial.
Its just takes time and I think most thought we would be over £10 by now,
2p not unrealistic on hype alone
A recent interview he said FME were valued 5 times less than similar competitors.
Its just a matter to exposure and time
This is going to rocket soon
Yes or no to following
Has SS brought shareholder value
Has Horsehill been a success
Have UKOG done well in Turkey
Did The CEO get his pants pulled down by old ladies who were able to argue better than him.
Has IoW planning gone well
Do UKOG have lost of cash left
Are funds required shortly
Has the BOD bought any of there own companies shares
Your answers to the above really should answer any questions you may have!!